These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7910447)

  • 21. The impact of varicella zoster virus: chronic pain.
    Opstelten W; McElhaney J; Weinberger B; Oaklander AL; Johnson RW
    J Clin Virol; 2010 May; 48 Suppl 1():S8-13. PubMed ID: 20510265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical herpes zoster presentation in a healthy vaccinated pediatric patient.
    Dagrosa AT; Collins LK; Chapman MS
    Cutis; 2017 Nov; 100(5):303-304. PubMed ID: 29232420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of shingles by varicella zoster virus vaccination.
    Holodniy M
    Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Herpes zoster and post-herpetic neuralgia in older adults].
    Lang PO; Zarate-Lagunes M; Pautex S
    Rev Med Suisse; 2008 Nov; 4(178):2398-402, 2404. PubMed ID: 19051627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic understanding and control of varicella-zoster virus infection.
    Asano Y
    Vaccine; 2008 Nov; 26(50):6487-90. PubMed ID: 18694794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herpes zoster: diagnostic, therapeutic, and preventive approaches.
    Bader MS
    Postgrad Med; 2013 Sep; 125(5):78-91. PubMed ID: 24113666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variations in herpes zoster manifestation.
    Wollina U
    Indian J Med Res; 2017 Mar; 145(3):294-298. PubMed ID: 28749391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A GVF Zoster Workshop.
    Johnson RW
    J Clin Virol; 2010 May; 48 Suppl 1():S1. PubMed ID: 20510261
    [No Abstract]   [Full Text] [Related]  

  • 29. Perspectives on vaccines against varicella-zoster virus infections.
    Gershon AA; Gershon MD
    Curr Top Microbiol Immunol; 2010; 342():359-72. PubMed ID: 20232192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune evasion as a pathogenic mechanism of varicella zoster virus.
    Abendroth A; Arvin AM
    Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herpes zoster in childhood.
    Leung AK; Robson WL; Leong AG
    J Pediatr Health Care; 2006; 20(5):300-3. PubMed ID: 16962434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A literature review regarding the management of varicella-zoster virus.
    Bond D; Mooney J
    Musculoskeletal Care; 2010 Jun; 8(2):118-22. PubMed ID: 20301227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Varicella and herpes zoster encephalitis].
    Fujita T; Umebayashi Y; Kikuchi M; Tojima H
    Ryoikibetsu Shokogun Shirizu; 1999; (24 Pt 2):22-4. PubMed ID: 10201125
    [No Abstract]   [Full Text] [Related]  

  • 34. Experimental models to study varicella-zoster virus infection of neurons.
    Steain M; Slobedman B; Abendroth A
    Curr Top Microbiol Immunol; 2010; 342():211-28. PubMed ID: 20373093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Varicella-zoster virus.
    Sheff B
    Nursing; 2000 Nov; 30(11):98. PubMed ID: 11111670
    [No Abstract]   [Full Text] [Related]  

  • 36. Varicella zoster vaccines.
    Creed R; Satyaprakash A; Ravanfar P
    Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Virus latency in infections with herpesviridae. Herpes simplex and varicella zoster virus: pathogenesis, clinical consequences].
    Schneweis KE
    Fortschr Med; 1989 Aug; 107(25):533-6. PubMed ID: 2553561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate.
    Mattiuzzi GN; Cortes JE; Talpaz M; Reuben J; Rios MB; Shan J; Kontoyiannis D; Giles FJ; Raad I; Verstovsek S; Ferrajoli A; Kantarjian HM
    Clin Cancer Res; 2003 Mar; 9(3):976-80. PubMed ID: 12631595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updated proceedings of the 2nd International Conference on the Varicella-Zoster Virus. Paris, France, July 7-8, 1994.
    Neurology; 1995 Dec; 45(12 Suppl 8):S1-79. PubMed ID: 8545006
    [No Abstract]   [Full Text] [Related]  

  • 40. Post-herpetic neuralgia case study: optimizing pain control.
    Baron R
    Eur J Neurol; 2004 Apr; 11 Suppl 1():3-11. PubMed ID: 15061819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.